Discoidin domain receptor 2 facilitates prostate cancer bone metastasis via regulating parathyroid hormone-related

Zhang Yan1, Su Jin2, Zhang Wei3

  • 1Center for Translational Medicine, The First Affiliated Hospital of Xi'an Jiaotong University College of Medicine, Xi'an, PR China.

Insights

Discoidin domain receptor 2 (DDR2) drives prostate cancer bone metastasis by promoting cell invasion and altering bone remodeling. Targeting DDR2 may offer new strategies against skeletal complications in prostate cancer patients.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Prostate cancer commonly metastasizes to bone, causing significant morbidity.
  • The molecular mechanisms underlying prostate cancer bone metastasis are not fully understood.
  • Discoidin domain receptor 2 (DDR2), a collagen-binding receptor tyrosine kinase (RTK), is implicated in cancer progression.

Purpose of the Study:

  • To investigate the role and mechanism of DDR2 in prostate cancer bone metastasis.
  • To elucidate how DDR2 influences prostate cancer cell behavior and bone microenvironment interactions.

Main Methods:

  • Analysis of DDR2 expression in prostate cancer tissues and cells.
  • In vitro studies using prostate cancer cell lines with altered DDR2 expression (overexpression and knockdown via shRNA).
  • Assessment of cell motility, invasiveness, proliferation, osteoblast differentiation, and osteoclast differentiation.
  • In vivo bone metastasis model using intrabone injection.
  • Molecular analyses of parathyroid hormone-related protein (PTHrP) regulation and TGF-β signaling.

Main Results:

  • DDR2 expression is significantly elevated in bone-metastatic prostate cancer.
  • DDR2 overexpression enhances prostate cancer cell motility and invasiveness.
  • DDR2 knockdown inhibits prostate cancer cell proliferation, osteoblast function, and osteoclast differentiation/bone resorption.
  • DDR2 promotes osteolytic bone metastasis in vivo.
  • DDR2 regulates PTHrP expression and activity via Runx2.
  • DDR2 interacts with TGF-β signaling and facilitates cancer cell adhesion to collagen.

Conclusions:

  • DDR2 plays a critical role in promoting prostate cancer bone metastasis.
  • DDR2 influences both cancer cell aggressiveness and bone microenvironment remodeling.
  • Understanding DDR2's mechanism provides potential therapeutic targets for treating prostate cancer bone metastasis.

Related Concept Videos

The Parathyroid Glands00:59

The Parathyroid Glands

The two pairs of parathyroid glands embedded within the posterior surface of the thyroid gland are restricted by a dense capsule around them. These glands comprise two distinct cell populations—parathyroid oxyphil and parathyroid principal cells- pivotal in calcium homeostasis.
Oxyphil cells, whose functions remain elusive, emerge during late puberty, adding a layer of complexity to the parathyroid gland's intricacies. In contrast, principal parathyroid cells undertake a vital role by...
5.2K
Hormones and Bone Tissue01:17

Hormones and Bone Tissue

The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
3.5K
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
2.0K
Calmodulin-dependent Signaling01:16

Calmodulin-dependent Signaling

Calmodulin (CaM) is a calcium-binding protein in eukaryotes that controls various calcium-regulated cellular processes. It has four calcium-binding sites that bind calcium to form the calcium-calmodulin ( Ca2+-CaM) complex. GPCR stimulation increases the calcium levels in the cells that bind to CaM and induces a conformational change.
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
5.0K
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
4.4K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.6K